Benchmarking ClinicalTrials.gov Usage and PRS Data Quality Review Findings: A Cross-Industry Survey and Remediation Framework
Project Description |
This project aims to address key evidence gaps in the use of ClinicalTrials.gov by generating quantitative insights into how organisations use the registry for regulatory compliance, global transparency requirements and voluntary disclosure practices. It will also explore recurring data quality review findings identified during PRS submissions and assess how these challenges are currently addressed across the industry. The project will establish a cross-industry, multi-stakeholder team working through two dedicated subgroups. One subgroup will develop a survey to evaluate ClinicalTrials.gov usage patterns and regulatory drivers, while the second will focus on common PRS data quality review findings and potential approaches for their resolution. By analysing anonymised survey data, the project will identify trends, challenges and opportunities to improve reporting consistency, data quality and submission efficiency. Findings will be shared through collaborative discussions and published in a white paper, providing evidence-based recommendations to support more reliable and timely disclosure of clinical trial information. |
Project Leads | |
|---|---|
Ritama Gupta, Merck | |
Sanjay Bagani, Xogene Services | |
Alex Pearce, PHUSE Project Coordinator |